How would you summarize the status of the current arsenal for AD and, in particular, the degree to which new systemic therapies are addressing the unmet for long-term disease management in the pediatric and adolescent population?
How would you summarize the status of the current arsenal for AD and, in particular, the degree to which new systemic therapies are addressing the unmet for long-term disease management in the pediatric and adolescent population?
Presenter
Chief of Pediatric and Adolescent Dermatology
Rady Children's Hospital-San Diego
Vice Chair, Department of Dermatology
Professor of Dermatology and Pediatrics
UC San Diego School of Medicine